IPC
EXAS

Independent Portfolio Consultants’s Exact Sciences EXAS Stock Holding History

Independent Portfolio Consultants’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-9,425
Closed -$87K – 763
2015
Q4 		$87K Buy
+9,425
New +$87.6K 0.03% 497

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

Independent Portfolio Consultants's EXAS Position: Q1 2016 in Review

Independent Portfolio Consultants sold out of Exact Sciences (EXAS) in Q1 2016, closing a stake of 9,425 shares — an estimated $87K sold.

Independent Portfolio Consultants first reported a position in EXAS in Q4 2015 and held it in 1 quarter. The position peaked at $87K in Q4 2015. 167 funds tracked by Wall St. Rank hold EXAS as of Q1 2016.

  • Independent Portfolio Consultants reported no remaining Exact Sciences position as of Q1 2016 after selling out during the quarter.
  • Independent Portfolio Consultants sold 9,425 Exact Sciences shares in Q1 2016, an estimated $87K.
  • Independent Portfolio Consultants first reported a position in Exact Sciences in Q4 2015 and held it in 1 quarter.
  • Independent Portfolio Consultants's Exact Sciences position peaked at $87K in Q4 2015.
  • 167 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2016.

Based on Independent Portfolio Consultants's 13F filing for Q1 2016, filed 13 Apr 2016.